Brenton‐Rule, Angela https://orcid.org/0000-0002-4152-5511
Dalbeth, Nicola
Edwards, N. Lawrence
Rome, Keith
Article History
Received: 9 October 2018
Accepted: 25 December 2018
First Online: 8 January 2019
Ethics approval and consent to participate
: This study was approved by the Auckland University of Technology Ethics Committee (16/75). Consent was obtained via submission of the completed survey.
: Not applicable.
: Dr. Dalbeth reports personal fees from Takeda, AstraZeneca/Ardea, Kowa, Horizon, Pfizer, Janssen, Abbvie; grants from AstraZeneca/Ironwood, Amgen, outside the submitted work. Dr. Edwards reports consultation fees from Takeda, Ironwood, Horizon and SOBI Pharmaceuticals and represents no conflicts with this study. AUT receives funding from ASICS New Zealand to support general podiatric research.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.